APA (7th ed.) Citation

Chen, E. J., Sowalsky, A. G., Gao, S., Cai, C., Voznesensky, O., Schaefer, R., . . . Taplin, M. (2015). Abiraterone Treatment in Castration-Resistant Prostate Cancer Selects for Progesterone Responsive Mutant Androgen Receptors. Clinical cancer research, 21(6), 1273-1280. https://doi.org/10.1158/1078-0432.CCR-14-1220

Chicago Style (17th ed.) Citation

Chen, Eddy J., et al. "Abiraterone Treatment in Castration-Resistant Prostate Cancer Selects for Progesterone Responsive Mutant Androgen Receptors." Clinical Cancer Research 21, no. 6 (2015): 1273-1280. https://doi.org/10.1158/1078-0432.CCR-14-1220.

MLA (9th ed.) Citation

Chen, Eddy J., et al. "Abiraterone Treatment in Castration-Resistant Prostate Cancer Selects for Progesterone Responsive Mutant Androgen Receptors." Clinical Cancer Research, vol. 21, no. 6, 2015, pp. 1273-1280, https://doi.org/10.1158/1078-0432.CCR-14-1220.